The SUVmean was lower in individuals with type 2 diabetes who received glucose-lowering drugs (oral glucose-lowering drugs and/or exogenous insulin) compared with those who were prescribed dietary and lifestyle changes (4.5±2.0 vs 6.1±2.5, p=0.15). The gene discussed is INS; the disease is type 2 diabetes mellitus.